Related Experiment Video

Updated: Apr 15, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

8.5K

Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review

Hitesh Jagani1, Narayanan Kasinathan1, Sreenivasa Reddy Meka2

  • 1a Department of Pharmaceutical Biotechnology , Manipal College of Pharmaceutical Sciences, Manipal University , Manipal , Karnataka , India.

Artificial Cells, Nanomedicine, and Biotechnology
|March 25, 2015
PubMed

Insights

Bcl-2 protein is a cancer target. RNA interference (RNAi) can reduce Bcl-2 expression, but effective delivery systems are needed for this cancer therapy approach.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Bcl-2 is an antiapoptotic protein with proven oncogenic potential, making it a significant target in cancer therapy.
  • Antisense technology and RNA interference (RNAi) are established methods for downregulating Bcl-2 gene expression.
  • These RNA-based strategies have shown efficacy as adjuvant therapies alongside traditional chemotherapeutic agents.

Purpose of the Study:

  • To review the role of the antiapoptotic Bcl-2 protein in oncogenesis.
  • To discuss various therapeutic strategies targeting Bcl-2.
  • To highlight the challenges and advancements in delivery systems for RNAi-based cancer therapies.

Main Methods:

  • Literature review of studies on Bcl-2 function, oncogenic potential, and therapeutic targeting.
  • Analysis of different approaches for modulating Bcl-2 expression, including antisense technology and RNA interference (RNAi).
  • Examination of various delivery systems designed for small interfering RNA (siRNA) in cancer treatment.

Main Results:

  • Bcl-2 overexpression contributes to cancer cell survival and resistance to apoptosis.
  • RNAi offers a promising strategy to inhibit Bcl-2, potentially sensitizing cancer cells to treatment.
  • The efficacy of RNAi is significantly limited by the lack of efficient and specific delivery systems for siRNA.

Conclusions:

  • Targeting Bcl-2 is a viable strategy for cancer treatment.
  • RNA interference presents a powerful tool for Bcl-2 gene silencing.
  • Development of effective siRNA delivery systems is crucial for advancing RNAi-based cancer therapies.
Keywords:
Antisense oligonucleotideBcl-2RNA interferenceapoptosiscancerdrug delivery

More Related Videos

Identifying Protein-protein Interaction Sites Using Peptide Arrays07:44

Identifying Protein-protein Interaction Sites Using Peptide Arrays

Published on: November 18, 2014

18.8K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.3K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K